OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 150 filers reported holding OCULAR THERAPEUTIX INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $44 | -99.9% | 15,814 | +19.1% | 0.00% | -20.0% |
| Q3 2022 | $55,000 | -73.9% | 13,274 | -37.0% | 0.01% | -80.0% |
| Q3 2021 | $211,000 | -37.2% | 21,066 | -11.1% | 0.02% | -26.5% |
| Q2 2021 | $336,000 | -1.8% | 23,702 | +13.8% | 0.03% | -12.8% |
| Q1 2021 | $342,000 | +12.5% | 20,828 | -47.9% | 0.04% | -20.4% |
| Q3 2020 | $304,000 | +192.3% | 39,974 | +90.7% | 0.05% | +145.0% |
| Q1 2020 | $104,000 | +23.8% | 20,960 | -0.6% | 0.02% | +33.3% |
| Q4 2018 | $84,000 | -56.9% | 21,077 | +0.1% | 0.02% | -67.4% |
| Q1 2017 | $195,000 | -34.1% | 21,062 | -40.6% | 0.05% | -41.8% |
| Q4 2016 | $296,000 | – | 35,458 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |